Breakthrough bioactives for skin health using the world's most advanced ex vivo discovery engine

Our mission is to improve human skin health by discovering and developing novel bioactives that are more effective and safer than anything available today.

Founded by a scientific team with deep experience engineering advanced organ systems, our fully-integrated technology platform combines complex, long-lasting, clinically-relevant ex vivo skin models with multimodal data analysis and predictive machine learning.  

We look forward to sharing more about our science-based approach to identifying effective and safe compounds at an unprecedented scale for use in health, skincare and cosmetic products.


Michael Polansky
Chief Executive Officer
James Coon
Executive Chairman
Stan King II
Chief Business Officer
Kyung-Jin (KJ) Jang
Chief Science Officer
Chris Hinojosa
Chief Technology Officer